Major Players Operating in the Global Bioreactors Market 2019-2023Posted by Melisa on August 6th, 2019 There has been a growing demand for single-use bioreactors in recent years as single-use bioreactors are easy to use and can be easily set up for continuous processing. Single-use bioreactors can also be easily customized to cater to the requirements of a continuous processing operation, eliminating the need for extensive re-work of the facility infrastructure and investments. Moreover, as single-use bioreactors do not require the same piping infrastructure and utilities, maintenance costs are significantly reduced. These advantages are expected to boost the demand for single-use bioreactors in the coming years. Furthermore, this industry research report also presents a competitive analysis of the market by end-users (biopharmaceutical companies, research institutes, and contract research organizations) and geography (North America, Europe, Asia, and ROW). Competitive vendor landscape “Biopharmaceutical companies will account for the highest growth in the global bioreactors market during the forecast period because of the growing demand for oncology drugs. The increasing adoption of bioreactors for drug development and gene therapy will also drive bioreactors market growth in this end-user segment,” says a senior analyst at Technavio Top five bioreactors market vendors Danaher Danaher operates in four segments: life sciences, diagnostics, dental, environmental & applied solutions. The company’s key offerings include: iCELLis Bioreactor. This product is offered as a single-use, automated, and fixed-bed bioreactor, and provides excellent cell growth conditions for adherent cells GE Healthcare GE Healthcare operates through three segments: healthcare systems, life sciences, and healthcare digital. Its key offerings include: Xcellerex XDR 10 single-use stirred-tank bioreactor. This product is offered as a flexible, stirred-tank bioreactor system for use in small-scale production, process development, and process troubleshooting. Merck KGaA Merck KGaA operates through three segments: healthcare, life science, and performance materials. The company’s key offerings include: Mobius Single-use Bioreactors. This product is a stirred tank bioreactor for use in suspension and adherent cell culture applications. Sartorius Sartorius operates through two segments: bioprocess solutions and lab products & services. The company’s key offerings include: ambr 15 cell culture. This product is used for 24 or 48 parallel cultivations in a cost-effective, 10–15 mL micro bioreactor format. Thermo Fisher Scientific Thermo Fisher Scientific operates through four segments: life sciences solutions, analytical instruments, specialty diagnostics, laboratory products and services. The company’s key offerings include: open architecture single-use bioreactors and integrated single-use bioreactors. Looking for more information on this market? Request a free sample report Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more. About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Like it? Share it! More by this author |